Equitable Trust CO Novo Nordisk A S Transaction History

Equitable Trust CO

$1.93 Billion
Q2 2025

A detailed history of Equitable Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Equitable Trust CO holds 49,085 shares of NVO stock, worth $2.46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

49,085

Previous 67,127 26.88%

Holding current value

$2.46 Million

Previous $4.66 Million 27.33%

% of portfolio

0.18%

Previous 0.27%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$58.08 - $81.05 $1.05 Million - $1.46 Million	-18,042 Reduced 26.88%	49,085 $3.39 Million
Q1 2025 May 07, 2025	SELL	$69.3 - $90.95 $1.07 Million - $1.41 Million	-15,504 Reduced 18.76%	67,127 $4.66 Million
Q4 2024 Jan 29, 2025	SELL	$85.0 - $120.04 $198,815 - $280,773	-2,339 Reduced 2.75%	82,631 $7.11 Million
Q3 2024 Nov 01, 2024	SELL	$119.07 - $145.42 $131,929 - $161,125	-1,108 Reduced 1.29%	84,970 $10.1 Million
Q2 2024 Aug 01, 2024	BUY	$122.71 - $146.91 $317,573 - $380,203	2,588 Added 3.1%	86,078 $12.3 Million
Q1 2024 Apr 25, 2024	SELL	$102.11 - $135.92 $127,024 - $169,084	-1,244 Reduced 1.47%	83,490 $10.7 Million
Q4 2023 Jan 25, 2024	SELL	$87.78 - $105.45 $257,458 - $309,284	-2,933 Reduced 3.35%	84,734 $8.77 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $4.44 Million - $9.75 Million	48,847 Added 125.83%	87,667 $7.97 Million
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $52,097 - $57,665	-334 Reduced 0.85%	38,820 $6.28 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $521,419 - $627,011	-3,940 Reduced 9.14%	39,154 $6.23 Million
Q4 2022 Feb 21, 2023	SELL	$102.55 - $135.33 $472,345 - $623,329	-4,606 Reduced 9.66%	43,094 $5.83 Million
Q3 2022 Nov 03, 2022	SELL	$95.28 - $116.93 $535,664 - $657,380	-5,622 Reduced 10.54%	47,700 $4.75 Million
Q2 2022 Jul 15, 2022	BUY	$103.24 - $121.81 $1.35 Million - $1.6 Million	13,118 Added 32.63%	53,322 $5.94 Million
Q1 2022 May 06, 2022	BUY	$93.1 - $112.54 $3.23 Million - $3.9 Million	34,678 Added 627.54%	40,204 $4.47 Million
Q3 2021 Oct 26, 2021	SELL	$84.42 - $106.62 $675 - $852	-8 Reduced 0.14%	5,526 $530,000
Q2 2021 Aug 03, 2021	BUY	$67.66 - $84.76 $5,683 - $7,119	84 Added 1.54%	5,534 $464,000
Q1 2020 May 21, 2020	SELL	$49.46 - $64.78 $54,356 - $71,193	-1,099 Reduced 16.78%	5,450 $328,000
Q4 2019 Feb 18, 2020	BUY	$49.86 - $58.26 $1,445 - $1,689	29 Added 0.44%	6,549 $379,000
Q2 2019 Aug 16, 2019	BUY	$46.79 - $52.47 $701 - $787	15 Added 0.23%	6,520 $333,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $6,768 - $7,683	146 Added 2.3%	6,505 $340,000
Q4 2018 Feb 22, 2019	BUY	$41.54 - $47.25 $27,541 - $31,326	663 Added 11.64%	6,359 $293,000
Q3 2018 Nov 15, 2018	SELL	$46.76 - $51.24 $2,384 - $2,613	-51 Reduced 0.89%	5,696 $269,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $254,534 - $289,763	5,747 New	5,747 $265,000

Others Institutions Holding NVO

# of Institutions

1,759

Shares Held

338M

Call Options Held

11M

Put Options Held

15.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $113B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Novo Nordisk A S Transaction History